Literature DB >> 12576821

Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy.

Joachim Leissner1, Christiane Koeppen, Helmut K Wolf.   

Abstract

PURPOSE: Data on the prognostic significance of tumor invading lymphatic and blood vessels in bladder cancer are controversial, while little is known about perineural invasion in this tumor. We determined the prognostic value of these parameters in radical cystectomy specimens.
MATERIALS AND METHODS: Slides of 283 radical cystectomy specimens obtained from 1986 to 1997 were examined retrospectively with respect to tumor invasion in lymphatic and blood vessels, and perineural spaces. This review was performed while blinded to lymph node tumor involvement or the postoperative disease course. The Kaplan-Meier probability analysis of tumor-free survival and the log rank test were used to determine the prognostic effects of vascular and perineural invasion. Multivariate analysis using the Cox proportional hazards model was also performed.
RESULTS: Lymphatic, blood vessel and perineural tumor invasion were present in 54.1%, 13.1% and 47.7% of specimens, respectively. Tumor progressed in 46.3% of patients. On univariate analysis all 3 factors showed strong prognostic significance. However, on multivariate analysis only blood vessel invasion, invasion depth and regional lymph node status were independent prognostic factors (p <0.05).
CONCLUSIONS: Lymph node metastases, pT classification and blood vessel invasion are independent prognostic parameters of tumor-free survival that should be used to guide patient treatment after radical cystectomy. Invasion of the blood and lymphatic vessels should be commented on separately in the pathology report.

Entities:  

Mesh:

Year:  2003        PMID: 12576821     DOI: 10.1097/01.ju.0000043639.55877.17

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  20 in total

Review 1.  Urothelial carcinoma of the bladder: definition, treatment and future efforts.

Authors:  Sandip M Prasad; G Joel Decastro; Gary D Steinberg
Journal:  Nat Rev Urol       Date:  2011-10-11       Impact factor: 14.432

2.  Perineural spread in pelvic malignancies can be an alternate explanation for pelvic bony metastases rather than hematogenous spread. A report of two cases.

Authors:  Stepan Capek; Benjamin M Howe; Adam T Froemming; Kimberly K Amrami; Robert J Spinner
Journal:  Skeletal Radiol       Date:  2015-04-12       Impact factor: 2.199

3.  Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial.

Authors:  Friedrich-Carl von Rundstedt; Douglas A Mata; Susan Groshen; John P Stein; Donald G Skinner; Walter M Stadler; Richard J Cote; Oleksandr N Kryvenko; Guilherme Godoy; Seth P Lerner
Journal:  BJU Int       Date:  2015-03-25       Impact factor: 5.588

4.  Risk stratification of survival by lymphovascular invasion, pathological stage, and surgical margin in patients with bladder cancer treated with radical cystectomy.

Authors:  Tatsuo Gondo; Jun Nakashima; Choichiro Ozu; Yoshio Ohno; Yutaka Horiguchi; Kazunori Namiki; Kunihiko Yoshioka; Makoto Ohori; Tadashi Hatano; Masaaki Tachibana
Journal:  Int J Clin Oncol       Date:  2011-09-07       Impact factor: 3.402

5.  Lymphovascular invasion in radical cystectomy specimen: is it an independent prognostic factor in patients without lymph node metastases?

Authors:  Murugesan Manoharan; Devendar Katkoori; T A Kishore; Merce Jorda; Tony Luongo; Mark S Soloway
Journal:  World J Urol       Date:  2009-07-12       Impact factor: 4.226

Review 6.  What are the currently available and in development molecular markers for bladder cancer? Will they prove to be useful in the future?

Authors:  Mohamed Ismat Abdulmajed; Eyüp Burak Sancak; Berkan Reşorlu; Gydhia Zuhair Al-Chalaby
Journal:  Turk J Urol       Date:  2014-10-15

Review 7.  Contemporary management of muscle-invasive bladder cancer.

Authors:  Faysal A Yafi; Jordan R Steinberg; Wassim Kassouf
Journal:  Int J Clin Oncol       Date:  2008-12-18       Impact factor: 3.402

Review 8.  Practical use of perioperative chemotherapy for muscle-invasive bladder cancer: summary of session at the Society of Urologic Oncology annual meeting.

Authors:  Andrea B Apolo; Herbert Barton Grossman; Dean Bajorin; Gary Steinberg; Ashish M Kamat
Journal:  Urol Oncol       Date:  2012 Nov-Dec       Impact factor: 3.498

9.  Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer.

Authors:  G Viale; A Giobbie-Hurder; B A Gusterson; E Maiorano; M G Mastropasqua; A Sonzogni; E Mallon; M Colleoni; M Castiglione-Gertsch; M M Regan; K N Price; R W Brown; R Golouh; D Crivellari; P Karlsson; C Öhlschlegel; R D Gelber; A Goldhirsch; A S Coates
Journal:  Ann Oncol       Date:  2009-07-24       Impact factor: 32.976

10.  Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy.

Authors:  Yohei Horikawa; Teruaki Kumazawa; Shintaro Narita; Takamitsu Inoue; Takeshi Yuasa; Shinobu Matsuura; Hiroshi Nanjo; Shigeru Satoh; Norihiko Tsuchiya; Tomonori Habuchi
Journal:  Int J Clin Oncol       Date:  2007-04-27       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.